PD-1 Checkpoint Inhibitor Associated Autoimmune Encephalitis

Case Reports in Oncology - Switzerland
doi 10.1159/000477162
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

S. Karger AG

Related search

Analysis of Blimp-1 and PD-1/PD-L1 Immune Checkpoint in an Autoimmune Thyroiditis Animal Model

International Journal of Endocrinology
EndocrineEndocrinologyMetabolismAutonomic SystemsDiabetes
2020English

Hyponatraemia Associated With Autoimmune Limbic Encephalitis

Endocrine Abstracts
2018English

PD-1 Checkpoint Blockade in Combination With an mTOR Inhibitor Restrains Hepatocellular Carcinoma Growth Induced by Hepatoma Cell-Intrinsic PD-1

Hepatology
MedicineHepatology
2017English

Elevated Adenosine Deaminase Levels in the Cerebrospinal Fluid in Immune Checkpoint Inhibitor-Induced Autoimmune Encephalitis: A Report of Two Cases

Internal Medicine
Internal MedicineMedicine
2019English

Posttransplant Autoimmune Encephalitis

Neurology: Neuroimmunology and NeuroInflammation
Neurology
2018English

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

Breast Care
SurgeryOncology
2016English

HDAC Inhibitor, CG-745, Enhances the Anti-Cancer Effect of Anti-Pd-1 Immune Checkpoint Inhibitor by Modulation of the Immune Microenvironment

Journal of Cancer
Oncology
2020English

Diagnosing Autoimmune Limbic Encephalitis

CMAJ
Medicine
2019English

Reporting of Immune Checkpoint Inhibitor-Associated Myocarditis – Authors' Reply

The Lancet
Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy